Bioline Rx's market cap is currently 58.83M. The company's EPS TTM is 0; its P/E ratio is ―; Bioline Rx is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is -0.33. See an overview of income statement, balance sheet, and cash flow financials.
